Reducing the cost of instrument ownership

April 2000
Life Science Today;Apr2000, Vol. 1 Issue 2, p16
Outlines the cost-effective approaches in evaluating process control and analysis instrumentation in pharmaceutical manufacture. Stringency of government regulations in drug development; Need for an independent third-party information to evaluate an instrument's performance; Availability of services from accredited instrument evaluation laboratories.


Related Articles

  • Building Automation Systems in a PAT Framework. Whitney, Jonathan T.; Granger, Mark A. // BioPharm International;Sep2005, Vol. 18 Issue 9, p70 

    Reports on the role of building automation technology system in maintaining and validating quality manufacturing environments in the U.S. Provision of closed-loop feedback control and analysis of the process of manufacturing a quality environment with optimum temperature; Details on the...

  • Detecting trouble early with CBM. Kurfess, Thomas R. // Control Engineering;Jul2007, Vol. 54 Issue 7, p36 

    The author reflects on the benefits of condition based maintenance (CBM) as a significant time and money saver across a broad spectrum of industrial applications. He describes two ways to successfully maintain machines used in a bearing production facility including having a number of...

  • Removing Variability. Jancsurak, Joe // Appliance Manufacturer;Sep2001, Vol. 49 Issue 9, p53 

    Looks at the time-pulse dispensing process adopted by Mountain View Fabricating for its grease-dispensing assembly operation. Principle behind the process; Benefits.

  • Diffusion Approximation for GX/GY/r+s Machine Repair Problem (MRP) with mixed Spares, Balking, Reneging and Additional Removable Repairmen. Singh, Neetu; Jain, Madhu; Sharma, G. C. // Journal of King Abdulaziz University: Engineering Sciences;1/ 1/2013, Vol. 24 Issue 1, p47 

    In this paper we consider machine repair problem (MRP) with mixed spares, balking, reneging and additional removable repairmen. The operating and spare units are subject to failure and repair in batches. The inter-failure and repair times are assumed to be general identical and independently...

  • Pursuing Efficiency: New Developments in Cleaning Technology. Chiarello-Ebner, Kaylynn // Pharmaceutical Technology;Mar2006, Vol. 30 Issue 3, p52 

    The article reports on developments in cleaning technology. It features analytical tools and methods that require less water and detergent. The article emphasizes the importance of cleaning verification of manufacturing equipment in drug production. It also details the efforts of pharmaceutical...

  • Quality by Design for Analytical Methods. Nethercote, Phil; Ermer, Joachim // Pharmaceutical Technology Europe;Oct2012, Vol. 24 Issue 10, p52 

    Adoption of quality-by-design (QbD) concepts in pharmaceutical development and manufacture is becoming increasingly well-established. QbD concepts are aimed at improving the robustness of manufacturing processes based upon adopting a systematic and scientific approach to development and...

  • Early Development GMPs for Stability An Industry Perspective (Part IV). Acken, Bruce; Alasandro, Mark; Colgan, Stephen; Curry, Paul; Diana, Frank; Li, Q. Chan; Li, Z. Jane; Mazzeo, Tony; Rignall, Andy; Tan, Z. Jessica; Timpano, Robert // Pharmaceutical Technology Europe;Oct2012, Vol. 24 Issue 10, p61 

    The authors, part of the International Consortium on innovation and Quality in Pharmaceutical Development (IQ Consortium), explore and define common industry approaches and practices when applying GMPs in early development. A working group of the consortium aims to develop a set of...

  • Deficiencies Found in API Inspections. Rosa, Carmelo; Katz, Paula R.; Mozzachio, Alicia // Pharmaceutical Technology Europe;Dec2013, Vol. 25 Issue 12, p20 

    The article discusses the effort of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme (PIC/s) in training inspectors to ensure uniformity and exchange of information in active pharmaceutical ingredients (API) inspection. It provides overview of the most...

  • Increased Efficiency Key to Competitiveness in Downstream Bioprocessing. Challener, Cynthia A. // Pharmaceutical Technology;Apr2014, Vol. 38 Issue 4, p24 

    The article focuses on the downstream processes in manufacturing in the biopharmaceutical industry. It discusses the effects of higher antibody titers and a growing demand for smaller-volume, flexible manufacturing to meet local market needs to the downstream processing. Innovative technologies...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics